Litcius/Paper detail

COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach

Giovanna Borriello, Antonio Ianniello

2020Multiple Sclerosis and Related Disorders40 citationsDOIOpen Access PDF

Topics & Concepts

NatalizumabMedicineContext (archaeology)Multiple sclerosisDosingPandemicIntensive care medicinePopulationAirwayImmunologyInternal medicineDiseaseCoronavirus disease 2019 (COVID-19)SurgeryInfectious disease (medical specialty)BiologyEnvironmental healthPaleontologyLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach | Litcius